:CAR

Richard Smith1

  • 1Department of Research, Kite, a Gilead Company, 5858 Horton Street, Suite 240, Emeryville, CA 94070, USA.

Antibody therapeutics
|October 17, 2023
PubMed
概括

化学抗原受体 (CAR) -T细胞疗法正在超越B细胞癌症. 在新的应用中,选择正确的结合域对于CAR-T细胞的有效性,强度和耐用性至关重要.